Penumbra completes enrollment for acute ischemic stroke study

Penumbra completed enrollment in its THUNDER clinical study for patients with acute ischemic stroke. THUNDER is evaluating the safety and efficacy of the company’s latest computer assisted vacuum thrombectomy – CAVT -technology, Penumbra System with Thunderbolt Aspiration Tubing, for the removal of blood clots in the brain. Penumbra System with Thunderbolt Aspiration Tubing uses an advanced CAVT software algorithm to generate proprietary modulated aspiration, reducing friction between the clot and reperfusion catheter and facilitating a more rapid and complete removal of blood clots in the brain. The study’s primary efficacy endpoint includes revascularization of the occluded target vessel at immediate post-procedure.